Tci Gene (ROCO:6879) Operating Cash Flow per Share : NT$0.67 (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Tci Gene Operating Cash Flow per Share?

Tci Gene's operating cash flow per share for the six months ended in Dec. 2023 was NT$-1.01. Tci Gene's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.67.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Tci Gene was -85.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -38.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Tci Gene's Operating Cash Flow per Share or its related term are showing as below:

ROCO:6879' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -38.7 Med: -21.25 Max: -3.8
Current: -38.7

During the past 5 years, Tci Gene's highest 3-Year average Operating Cash Flow per Share Growth Rate was -3.80% per year. The lowest was -38.70% per year. And the median was -21.25% per year.

ROCO:6879's 3-Year OCF Growth Rate is ranked worse than
84.87% of 1236 companies
in the Biotechnology industry
Industry Median: 3.35 vs ROCO:6879: -38.70

Tci Gene Operating Cash Flow per Share Historical Data

The historical data trend for Tci Gene's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene Operating Cash Flow per Share Chart

Tci Gene Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

5.04

2.92

6.02

4.49

0.67

Tci Gene Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial				5.35	1.48	2.88	1.68	-1.01

Competitive Comparison of Tci Gene's Operating Cash Flow per Share

For the Biotechnology subindustry, Tci Gene's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tci Gene's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tci Gene's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Tci Gene's Price-to-Operating-Cash-Flow falls into.

Tci Gene Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Tci Gene's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	17.849	/	26.482
	=	0.67

Tci Gene's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-26.782	/	26.468
	=	-1.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.67

Tci Gene Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Tci Gene's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Tci Gene (ROCO:6879) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN

Website

https://www.genext.me

Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines